APA (7th ed.) Citation

Y, L., L, Z., CE, N., SL, B., K, A., AE, R., . . . D, R. (2011). Quantitative pharmacokinetic/pharmacodynamic analyses suggest that the 129/SVE mouse is a suitable preclinical pharmacology model for identifying small-molecule γ-secretase inhibitors. The Journal of pharmacology and experimental therapeutics, 339(3), 922. https://doi.org/10.1124/jpet.111.186791

Chicago Style (17th ed.) Citation

Y, Lu, et al. "Quantitative Pharmacokinetic/pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-molecule γ-secretase Inhibitors." The Journal of Pharmacology and Experimental Therapeutics 339, no. 3 (2011): 922. https://doi.org/10.1124/jpet.111.186791.

MLA (9th ed.) Citation

Y, Lu, et al. "Quantitative Pharmacokinetic/pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-molecule γ-secretase Inhibitors." The Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 3, 2011, p. 922, https://doi.org/10.1124/jpet.111.186791.